Fierce Drug Dev Forum 2019 has ended
Back To Schedule
Monday, October 28 • 1:15pm - 2:00pm
Key Questions Small Companies Should Ask When Evaluating Potential Partners

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Consider common deal structures and requirements for the sellers to achieve milestones before receiving a full payout
  • Assess the sources of growth and where a potential partner stands in comparison to competitors
  • Analyze their core strengths and how to go about gathering detailed information about their finances and capabilities
  • Understand how to set up a successful integration using this process

avatar for Richard Brudnick

Richard Brudnick

Chief Business Officer and Head of Strategy, CODIAK BIOSCIENCES
avatar for Gil Labrucherie

Gil Labrucherie

Senior Vice President and Chief Financial Officer, NEKTAR THERAPEUTICS
avatar for Albert Hsia 

Albert Hsia 

Bussiness Development , MERCK & CO.
Albert Hsia focuses on partnership and M&A opportunities for Merck in immuno-oncology and immunology, as well as in new therapeutic modalities and platforms with potential across disease areas.  Merck builds strong partnerships with innovative biotechs globally, based on early-stage... Read More →
avatar for Robert Bagdorf

Robert Bagdorf

Group Lead, Search and Evaluation, Worldwide Business Development, PFIZER
avatar for Thomas Neenan

Thomas Neenan


Monday October 28, 2019 1:15pm - 2:00pm PDT